MedTrace Logo

Inflammation as a Predictor in Cardioversion of Atrial Fibrillation

NCT00590525 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2009-12-01

No results posted yet for this study

Summary

The laboratory test, C-Reactive Protein (CRP), has become well established as a marker of inflammation. Recently a high CRP level (indicating an increase in inflammation) was identified as a risk factor for atrial fibrillation. We are conducting this study with patients such as yourself with atrial fibrillation who are planning to undergo cardioversion to determine what sort of relationship exists between CRP levels and atrial fibrillation. We will then look at success rates of converting atrial fibrillation to normal sinus rhythm, compared to patients' CRP levels.

Conditions

Interventions

PROCEDURE

Cardioversion

Baseline hsCRP will be drawn the morning of, prior to, cardioversion. An EKG to document the patient's rhythm will be obtained at the one-month mark

Sponsors & Collaborators

  • Creighton University

    lead OTHER

Principal Investigators

  • Susan Schima, MD · Creighton University

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-10-31
Primary Completion
2009-06-30
Completion
2009-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00590525 on ClinicalTrials.gov